Delivery Order SPE2DB20D1051-SPE2DB25FD7YN

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Forteo 600 mcg/2.4 ml pen injections. The contract has a ceiling value of $3,252.95 and a period of performance through November 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Forteo 600 mcg/2.4 ml pen injections. The contract has a firm fixed price of $10,589.55 and a completion date of November 8, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Forteo 600 mcg/2.4 ml pen injections. The delivery order, valued at $3,666.64, has a period of performance through February 26, 2025 and is structured as a firm fixed-price contract. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Forteo 600 mcg/2.4 ml injection pens. The contract has a firm fixed price of $1,772.06 and an ultimate completion date of May 20, 2024. The contract is not set aside and was awarded on a full and open competition basis. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Forteo 600 mcg/2.4 ml pen injections. The contract has a ceiling value of $4,376.93 and a completion date of July 10, 2024. The contract is a firm fixed price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is one of the largest pharmaceutical distribution...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $1,772.06, is for the delivery of the pharmaceutical product Forteo 600 mcg/2.4 ml pen injection in 2.4 ml quantities. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award, valued at $4,289.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Forteo 560 mcg/2.24 ml pen injections. It is a firm-fixed-price delivery order with a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $20,742.59, is for the delivery of Forteo 600 mcg/2.4 ml pen injections. The contract is a firm fixed-price delivery order with a completion date of February 27, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Forteo 600 mcg/2.4 ml pen injections. The firm-fixed-price contract, valued at $17,954.86, is a delivery order that will run through August 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of Forteo 600 mcg/2.4 ml pen injection medication, with a potential value of $10,207.95 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is part of a...
  • SPE2DB20D1051
    Indefinite Delivery Contract
  • SPE2DB20D1051-SPE2DB25FD7YN
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Forteo 560 mcg/2.24 ml pen injections. The contract has a ceiling value of $12,869.67 and is a firm fixed-price, non-set-aside award with a performance period through May 2025.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agencies.

Generated 8/3/25, 12:56 AM